SMSPHARMA.BOSMSPHARMA.BOBSE
Loading
EBITDA as a percentage of revenue
3Y CAGR
+20.7%/yr
vs -13.4%/yr prior
5Y CAGR
-2.1%/yr
Recent acceleration
Acceleration
+34.1pp
Accelerating
Percentile
P67
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
3 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| TTM | 20.00% | +7.8% |
| 2025 | 18.55% | +12.0% |
| 2024 | 16.57% | +45.7% |
| 2023 | 11.38% | -51.0% |
| 2022 | 23.21% | +4.5% |
| 2021 | 22.21% | +6.4% |
| 2020 | 20.88% | +3.1% |
| 2019 | 20.25% | -2.6% |
| 2018 | 20.79% | +78.2% |
| 2017 | 11.66% | - |